1. Home
  2. NB vs SRTS Comparison

NB vs SRTS Comparison

Compare NB & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NB
  • SRTS
  • Stock Information
  • Founded
  • NB 1987
  • SRTS 2010
  • Country
  • NB United States
  • SRTS United States
  • Employees
  • NB N/A
  • SRTS N/A
  • Industry
  • NB Metal Mining
  • SRTS Medical/Dental Instruments
  • Sector
  • NB Basic Materials
  • SRTS Health Care
  • Exchange
  • NB Nasdaq
  • SRTS Nasdaq
  • Market Cap
  • NB 116.9M
  • SRTS 110.3M
  • IPO Year
  • NB N/A
  • SRTS 2016
  • Fundamental
  • Price
  • NB $2.23
  • SRTS $5.38
  • Analyst Decision
  • NB Strong Buy
  • SRTS Strong Buy
  • Analyst Count
  • NB 2
  • SRTS 2
  • Target Price
  • NB $3.63
  • SRTS $13.00
  • AVG Volume (30 Days)
  • NB 401.5K
  • SRTS 562.9K
  • Earning Date
  • NB 03-04-2025
  • SRTS 02-05-2025
  • Dividend Yield
  • NB N/A
  • SRTS N/A
  • EPS Growth
  • NB N/A
  • SRTS 1266.06
  • EPS
  • NB N/A
  • SRTS 0.41
  • Revenue
  • NB N/A
  • SRTS $41,807,000.00
  • Revenue This Year
  • NB N/A
  • SRTS $9.09
  • Revenue Next Year
  • NB N/A
  • SRTS $22.30
  • P/E Ratio
  • NB N/A
  • SRTS $13.64
  • Revenue Growth
  • NB N/A
  • SRTS 71.31
  • 52 Week Low
  • NB $1.27
  • SRTS $2.91
  • 52 Week High
  • NB $4.00
  • SRTS $9.33
  • Technical
  • Relative Strength Index (RSI)
  • NB 52.03
  • SRTS 37.03
  • Support Level
  • NB $2.34
  • SRTS $5.41
  • Resistance Level
  • NB $2.55
  • SRTS $5.88
  • Average True Range (ATR)
  • NB 0.29
  • SRTS 0.50
  • MACD
  • NB -0.05
  • SRTS -0.12
  • Stochastic Oscillator
  • NB 18.82
  • SRTS 0.54

About NB NioCorp Developments Ltd.

NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: